Intrinsic Value of S&P & Nasdaq Contact Us

Fluent Corp. CNTMF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
22/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Fluent Corp. (CNTMF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 21/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
22/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
54/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — CNTMF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.12
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.13
Book Value / Share$0.00
Revenue / Share$0.29
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.03 $0.00 $-1.89M -
2017 $-0.16 $0.00 $-10.14M -
2018 $0.00 $8.06M $-327K -4.1%
2019 $-0.29 $28.51M $-53.23M -186.7%
2020 $-0.18 $52.39M $-36.74M -70.1%
2021 $-0.08 $65.44M $-19M -29%
2022 $-0.15 $87.69M $-37.15M -42.4%
2023 $-0.08 $97.29M $-22.75M -23.4%
2024 $-0.13 $103.56M $-40.39M -39%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message